Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 58, Issue 3, Pages 1550-1555Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm5013243
Keywords
-
Categories
Funding
- National Health and Medical Research Council (NHMRC) [APP1049564, APP1055134]
Ask authors/readers for more resources
Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available